Latest filing published 23 Jul 2026 for MediPharm Labs Corp.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Michael Scott Bumby on record concern MediPharm Labs Corp. The record holds 2 filings, all for trades on 9 June 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 23 July 2026, the filings show an option exercise in MediPharm Labs Corp. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations